JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (48)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, A. K.
Right arrow Articles by Muir, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, A. K.
Right arrow Articles by Muir, K. T.
Related Collections
Right arrow Pediatrics
Right arrow Pharmacology
Anesth Analg 2001;93:1393-1401
© 2001 International Anesthesia Research Society


PEDIATRIC ANESTHESIA

Pharmacokinetics of Remifentanil in Anesthetized Pediatric Patients Undergoing Elective Surgery or Diagnostic Procedures

Allison Kinder Ross, MD*, Peter J. Davis, MD{dagger}, Guy deL. Dear, MB*, Brian Ginsberg, MB*, Francis X. McGowan, MD{ddagger}, Richard D. Stiller, PhD||||, Lynn Graham Henson, PharmD§, Cameron Huffman, MS§, and Keith T. Muir, PhD§

*Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; {dagger}Departments of Anesthesiology and Pediatrics, University of Pittsburgh School of Medicine, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; {ddagger}Department of Anesthesiology, Harvard Medical School, and Boston Children’s Hospital, Boston, Massachusetts; and §Glaxo Wellcome, Inc., Research Triangle Park, North Carolina

Address correspondence and reprint requests to Peter J. Davis, MD, Professor of Anesthesiology and Pediatrics, Department of Anesthesiology, Children’s Hospital of Pittsburgh, 3705 Fifth Ave., Pittsburgh, PA 15213-2583. Address e-mail to davis{at}smtp.anes.upmc.edu

Remifentanil hydrochloride is an ultra-short-acting opioid that undergoes rapid metabolism by tissue and plasma esterases. We aimed to characterize the pharmacokinetics and determine the hemodynamic profile of remifentanil after a single-bolus dose in children aged 0 to 18 yr. Forty-two children undergoing elective surgical procedures received remifentanil 5 µg/kg infused over 1 min. Patients were divided into age groups as follows: young infants (<=2 mo), older infants (>2 mo to <2 yr), young children (2 to <7 yr), older children (7 to <13 yr), adolescents (13 to <16 yr), and young adults (16 to <18 yr). Arterial blood samples were collected and analyzed by mass spectroscopy to determine remifentanil pharmacokinetic profiles. Hemodynamic measurements for remifentanil’s effect were made after the infusion. Methods of statistical analysis included analysis of variance and linear regression, with significance at P <= 0.05. Complete remifentanil pharmacokinetic data were obtained from 34 patients. The volume of distribution was largest in the infants <2 mo (mean, 452 mL/kg) and decreased to means of 223 to 308 mL/kg in the older patients. There was a more rapid clearance in the infants <2 mo of age (90 mL · kg-1 · min-1) and infants 2 mo to 2 yr (92 mL · kg-1 · min-1) than in the other groups (means, 46 to 76 mL · kg-1 · min-1). The half-life was similar in all age groups, with means of 3.4 to 5.7 min. Seven subjects (17%) developed hypotension related to the remifentanil bolus. Remifentanil showed an extremely rapid elimination similar to that in adults. The fast clearance rates observed in neonates and infants, as well as the lack of age-related changes in half-life, are in sharp contrast to the pharmacokinetic profile of other opioids. Remifentanil in a bolus dose of 5 µg/kg may cause hypotension in anesthetized children.

IMPLICATIONS: The pharmacokinetics of remifentanil were studied in children from birth to 18 yr. Remifentanil was found to have age-related changes in clearance and volume of distribution, but not half-life. The increased clearance observed in young infants is in contrast to other opioids.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
K. Y. Yoo, C. W. Jeong, B. Y. Park, S. J. Kim, S. T. Jeong, M. H. Shin, and J. Lee
Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia
Br. J. Anaesth., June 1, 2009; 102(6): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. Jeleazcov, H. Ihmsen, J. Schmidt, C. Ammon, H. Schwilden, J. Schuttler, and J. Fechner
Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children
Br. J. Anaesth., April 1, 2008; 100(4): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. E. Rigby-Jones, M. J. Priston, J. R. Sneyd, A. P. McCabe, G. I. Davis, M. A. Tooley, G. C. Thorne, and A. R. Wolf
Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery
Br. J. Anaesth., August 1, 2007; 99(2): 252 - 261.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
K. Reyntjens, L. Foubert, D. D. Wolf, G. Vanlerberghe, and E. Mortier
Glycopyrrolate during sevoflurane-remifentanil-based anaesthesia for cardiac catheterization of children with congenital heart disease
Br. J. Anaesth., November 1, 2005; 95(5): 680 - 684.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P.-A. Lonnqvist and N. S. Morton
Postoperative analgesia in infants and children
Br. J. Anaesth., July 1, 2005; 95(1): 59 - 68.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. R. Glaisyer and M. R. J. Sury
Recovery After Anesthesia for Short Pediatric Oncology Procedures: Propofol and Remifentanil Compared with Propofol, Nitrous Oxide, and Sevoflurane
Anesth. Analg., April 1, 2005; 100(4): 959 - 963.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. Chanavaz, O. Tirel, E. Wodey, J. Y. Bansard, L. Senhadji, J. C. Robert, and C. Ecoffey
Haemodynamic effects of remifentanil in children with and without intravenous atropine. An echocardiographic study
Br. J. Anaesth., January 1, 2005; 94(1): 74 - 79.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. K. Weale, C. A. Rogers, R. Cooper, J. Nolan, and A. R. Wolf
Effect of remifentanil infusion rate on stress response to the pre-bypass phase of paediatric cardiac surgery
Br. J. Anaesth., February 1, 2004; 92(2): 187 - 194.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
R. Yumul, A. Emdadi, and N. Moradi
Anesthesia for Noncardiac Surgery in Children with Congenital Heart Disease
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 153 - 165.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
P. J. Davis, R. L. Stiller, A. S. Wilson, F. X. McGowan, T. D. Egan, and K. T. Muir
In Vitro Remifentanil Metabolism: The Effects of Whole Blood Constituents and Plasma Butyrylcholinesterase
Anesth. Analg., November 1, 2002; 95(5): 1305 - 1307.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Rothstein
Remifentanil for Neonates and Infants: Piano, Piano Con Calma
Anesth. Analg., December 1, 2001; 93(6): 1370 - 1372.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2001 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.